GNH USA

Europe — EMA

Letybo

GNH USA supplies Letybo (Botulinum toxin type A), a muscle relaxant for cervical dystonia, spasticity and chronic migraine. Request a quote for global supply.

Botulinum Toxin Type A

Request sourcing

1
Pack/s

What is Botulinum Toxin Type A?

Botulinum toxin type A, the active ingredient in Letybo, is a botulinum toxin presented as a sterile injectable for intramuscular use. It temporarily reduces muscle activity by blocking acetylcholine release and is employed in several neuromuscular conditions. GNH USA supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Botulinum Toxin Type A used for?

Letybo is a botulinum toxin type A that acts on overactive muscle activity in several neurological conditions. - Cervical dystonia: reduces abnormal neck muscle contractions. - Blepharospasm: diminishes involuntary eyelid closure. - Upper‑limb spasticity: improves range of motion by relaxing spastic muscles. - Chronic migraine: decreases frequency of migraine attacks. - Primary axillary hyperhidrosis: limits excessive sweating by inhibiting sweat‑gland stimulation.

What are the side effects of Botulinum Toxin Type A?

Adverse reactions are generally related to the injection site and systemic spread of the toxin.

Common Side Effects: - Injection site pain or tenderness. - Localized bruising or hematoma. - Headache. - Transient muscle weakness near the injection area.

Serious or Rare Side Effects: - Dysphagia or difficulty swallowing. - Respiratory compromise due to spread to respiratory muscles. - Generalized botulism‑like syndrome with systemic weakness. - Vision changes such as blurred vision. - Severe allergic reaction (anaphylaxis).

What precautions apply to Botulinum Toxin Type A?

Before administering Letybo, clinicians should consider several safety factors. - Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown excretion; weigh potential risks. - Concomitant neuromuscular blocking agents: may enhance paralysis. - Active infection at intended injection site: postpone treatment. - Known hypersensitivity to botulinum toxin: contraindicated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Botulinum Toxin Type A interact with?

Botulinum toxin type A may interact with other agents that affect neuromuscular transmission.

Major Interactions (Avoid): - Aminoglycoside antibiotics: can potentiate neuromuscular blockade. - General anesthetic agents (e.g., succinylcholine): increased risk of prolonged paralysis. - Quinidine: may enhance toxin effect.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may reduce therapeutic efficacy. - Calcium channel blockers: possible additive effect on muscle tone.

Frequently asked questions

What conditions is Letybo used to treat?+
Letybo is indicated for several neuromuscular disorders, including cervical dystonia, blepharospasm, upper‑limb spasticity, chronic migraine prevention, and primary axillary hyperhidrosis. In each case the drug works by temporarily reducing overactive muscle activity, providing symptom relief and functional improvement.
How does botulinum toxin type A work in the body?+
Botulinum toxin type A cleaves the SNAP‑25 protein, which is essential for the release of acetylcholine at the neuromuscular junction. By blocking this neurotransmitter, the toxin prevents muscle contraction in the targeted area, leading to temporary paralysis and reduction of abnormal muscle activity.
What is the usual dose of Letybo?+
The dose of Letybo is individualized by the prescribing clinician based on the specific indication, severity of symptoms, and patient characteristics. The prescriber determines the appropriate amount, injection sites, and treatment intervals according to clinical guidelines and product labeling.
Is Letybo safe to use during pregnancy or breastfeeding?+
Safety data for Letybo in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk, and breastfeeding mothers should consider the unknown excretion into milk and discuss alternatives with their healthcare provider.
How do I order Letybo from GNH USA?+
To request Letybo, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and any required import documentation.
How does Letybo compare with other botulinum toxin products?+
Letybo contains botulinum toxin type A, the same active molecule found in other branded products such as Botox® and Dysport®. While the core mechanism is identical, differences may exist in formulation, unit potency, and approved indications. Clinical choice often depends on physician experience, regulatory approvals, and specific patient needs.
What are the storage requirements for Letybo?+
Letybo must be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the product. Proper cold‑chain handling ensures stability and maintains efficacy until the point of use.
How is Letybo administered?+
Letybo is delivered by a qualified healthcare professional via intramuscular injection. The clinician selects appropriate injection sites based on the targeted muscle group, uses a sterile technique, and may employ electromyographic or anatomical guidance to ensure accurate placement.
What are the most serious risks associated with Letybo?+
Serious risks include dysphagia, respiratory compromise, generalized muscle weakness resembling botulism, vision changes, and severe allergic reactions such as anaphylaxis. Prompt recognition and medical intervention are essential if any of these symptoms develop after treatment.
Who should not receive Letybo?+
Letybo is contraindicated in individuals with a known hypersensitivity to botulinum toxin type A or any of its excipients, and in patients with active infection at the intended injection site. Caution is also advised for those taking medications that affect neuromuscular transmission or with conditions that could exacerbate toxin spread.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Botulinum Toxin Type A
Route
Intramuscular Use
Manufacturer
Croma Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU